Charles River Adds New Biologics-Testing Facility
The new 73,000-square-foot facility is one of several expansions to support the company’s biologics testing capabilities.
On March 8, 2018, Charles River Laboratories, a contract research organization, announced the addition of a new 73,000-square-foot facility on Devon Park Road in Wayne, PA, that will more than double the laboratory space available at the company’s existing facilities in Malvern and King of Prussia, PA.
This latest announcement is one of several expansions made to the company’s biologics testing solutions infrastructure to support the characterization, development, and release of biologics and biosimilars.
Certain laboratory operations conducted at the Malvern and King of Prussia sites will begin to move to Devon Park early in the third quarter of 2018. The formal transfer of assays will be done in phases, and, during the transition, both the Malvern and King of Prussia facilities will remain fully operational.
“The high volume of biologics and biosimilars in development has led to a rapid increase in demand for our services,” said Greg Beattie, corporate vice president, Global Biologics Testing Solutions at Charles River, in a company press release. “The continued expansion of our [b]iologics service portfolio and additional capacity will further enhance our ability to support clients’ development efforts from discovery through clinical phases and commercial manufacturing.”
Source: Charles River Laboratories
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
